Quanterix Corporation (QTRX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$49.43M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$41.36M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$37.33M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$37.10M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$49.43M | (m) | $32.91M | (m) | $96.00K* | -$5.12M* | (m) | $7.82M | $27.35M | -$54.00K |
| 2026-03-31 | Reported | (m) | -$41.36M | (m) | $36.41M | (m) | $87.00K | -$18.11M | (m) | $7.32M | $29.77M | -$7.00K |
| 2025-09-30 | Reported | (m) | -$37.33M | (m) | $40.23M | (m) | $677.00K* | -$41.25M* | (m) | $8.01M | $39.06M | -$2.48M |
| 2025-06-30 | Reported | (m) | -$37.10M | (m) | $24.48M | (m) | $777.00K* | -$5.66M* | (m) | $9.08M | $30.35M | -$73.00K |
| 2025-03-31 | Reported | (m) | -$26.37M | (m) | $30.33M | (m) | $1.26M | -$13.89M | (m) | $10.04M | $31.17M | -$2.91M |
| 2024-09-30 | Reported | (m) | -$11.75M | (m) | $35.81M | (m) | $851.00K* | -$5.75M* | (m) | $8.10M | $22.91M | $145.00K |
| 2024-06-30 | Reported | (m) | -$10.94M | (m) | $34.38M | (m) | $1.60M* | -$4.95M* | (m) | $8.17M | $24.08M | $117.00K |
| 2024-03-31 | Reported | (m) | -$15.16M | (m) | $32.07M | (m) | $506.00K | -$20.16M | (m) | $6.74M | $26.04M | $180.00K |
| 2023-12-31 | Reported | (m) | -$13.62M | (m) | $31.55M | (m) | (m) | (m) | (m) | $7.21M | $23.44M | $141.00K |
| 2023-09-30 | Reported | (m) | -$12.81M | (m) | $31.56M | (m) | $931.00K* | -$3.87M* | (m) | $7.74M | $23.55M | $203.00K |
| 2023-06-30 | Reported | (m) | -$8.99M | (m) | $30.80M | (m) | $811.00K* | $1.03M* | (m) | $6.13M | $21.31M | $235.00K |
| 2023-03-31 | Reported | (m) | -$10.58M | (m) | $28.46M | (m) | $136.00K | -$9.82M | (m) | $4.99M | (m) | $140.00K |
| 2022-12-31 | Reported | (m) | -$21.39M | (m) | $25.82M | (m) | (m) | (m) | (m) | $5.84M | $18.39M | $154.00K |
| 2022-09-30 | Reported | (m) | -$37.95M | (m) | $26.65M | (m) | $3.68M* | -$14.80M* | (m) | $6.83M | $20.48M | $72.00K |
| 2022-06-30 | Reported | (m) | -$26.96M | (m) | $23.50M | (m) | $5.01M* | -$7.96M* | (m) | $7.26M | $27.82M | $137.00K |
| 2022-03-31 | Reported | (m) | -$17.95M | (m) | $29.55M | (m) | $1.33M | -$21.75M | (m) | $6.88M | $25.17M | -$199.00K |
| 2021-09-30 | Reported | (m) | -$15.23M | (m) | $27.69M | (m) | $3.82M* | -$13.78M* | (m) | $6.81M | $23.67M | $33.00K |
| 2021-06-30 | Reported | (m) | -$13.67M | (m) | $25.37M | (m) | $7.26M* | -$9.75M* | (m) | $6.75M | $20.79M | $41.00K |
| 2021-03-31 | Reported | (m) | -$9.79M | (m) | $27.21M | (m) | $79.00K | -$14.09M | (m) | $6.68M | $19.45M | -$42.00K |
| 2020-12-31 | Reported | (m) | -$9.93M | (m) | $26.13M | (m) | (m) | (m) | (m) | $6.22M | $18.77M | -$123.00K |
| 2020-09-30 | Reported | (m) | $2.28M | (m) | $31.39M | (m) | $788.00K* | -$7.42M* | (m) | $5.38M | $13.45M | -$111.00K |
| 2020-06-30 | Reported | (m) | -$12.20M | (m) | $13.13M | (m) | $935.00K* | -$7.42M* | (m) | $4.31M | $13.10M | -$18.00K |
| 2020-03-31 | Reported | (m) | -$11.73M | (m) | $15.73M | (m) | $426.00K | -$13.18M | (m) | $4.27M | $14.27M | -$124.00K |
| 2019-12-31 | Reported | (m) | -$11.49M | (m) | $15.92M | (m) | (m) | (m) | (m) | $4.40M | $13.95M | -$107.00K |
| 2019-09-30 | Reported | (m) | -$10.24M | (m) | $14.94M | (m) | $473.00K* | -$8.83M* | (m) | $3.92M | $13.35M | -$125.00K |
| 2019-06-30 | Reported | (m) | -$10.51M | (m) | $13.54M | (m) | $3.91M* | -$7.47M* | (m) | $4.02M | $13.43M | $23.00K |
| 2019-03-31 | Reported | (m) | -$9.36M | (m) | $12.34M | (m) | $5.92M | -$5.35M | (m) | $3.85M | $11.51M | $22.00K |
| 2018-12-31 | Reported | (m) | -$9.41M | (m) | $10.88M | (m) | (m) | (m) | (m) | $4.04M | $10.58M | $25.00K |
| 2018-09-30 | Reported | (m) | -$7.66M | (m) | $10.59M | (m) | $707.00K* | -$6.64M* | (m) | $4.41M | $8.85M | (m) |
| 2018-06-30 | Reported | (m) | -$7.31M | (m) | $8.64M | (m) | $242.00K* | -$3.91M* | (m) | $3.71M | $7.58M | (m) |
| 2018-03-31 | Reported | (m) | -$7.16M | (m) | $7.52M | (m) | $448.00K | -$10.06M | (m) | $3.64M | $6.69M | (m) |
| 2017-12-31 | Reported | (m) | -$7.09M | (m) | (m) | (m) | (m) | (m) | (m) | $3.93M | $6.05M | (m) |
| 2017-09-30 | Reported | (m) | -$6.39M | (m) | (m) | (m) | $130.00K* | -$7.49M* | (m) | $4.22M | $4.73M | (m) |
| 2017-06-30 | Reported | (m) | -$6.47M | (m) | (m) | (m) | $496.00K* | -$6.23M* | (m) | $3.90M | $4.75M | (m) |
| 2017-03-31 | Reported | (m) | -$6.06M | (m) | (m) | (m) | $167.00K | -$3.99M | (m) | $4.25M | $4.17M | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$125.54M | (m) | $138.90M | (m) | $2.61M | -$77.24M | (m) | $35.92M | $138.01M | -$5.12M |
| 2024-12-31 | Reported | (m) | -$52.62M | (m) | $137.42M | (m) | $3.37M | -$35.16M | (m) | $31.08M | $101.62M | $434.00K |
| 2024-09-30 | Rolling | (m) | -$51.46M* | (m) | $133.81M* | (m) | (m) | (m) | (m) | $30.23M* | $96.46M* | $583.00K* |
| 2024-06-30 | Rolling | (m) | -$52.52M* | (m) | $129.56M* | (m) | (m) | (m) | (m) | $29.86M* | $97.11M* | $641.00K* |
| 2024-03-31 | Rolling | (m) | -$50.57M* | (m) | $125.98M* | (m) | (m) | (m) | (m) | $27.82M* | $94.33M* | $759.00K* |
| 2023-12-31 | Reported | (m) | -$45.99M | (m) | $122.37M | (m) | $3.84M | -$18.85M | (m) | $26.06M | $89.11M | $719.00K |
| 2023-12-31 | Rolling | (m) | -$45.99M* | (m) | $122.37M* | (m) | (m) | (m) | (m) | $26.06M* | (m) | $719.00K* |
| 2023-09-30 | Rolling | (m) | -$53.77M* | (m) | $116.64M* | (m) | (m) | (m) | (m) | $24.70M* | (m) | $732.00K* |
| 2023-06-30 | Rolling | (m) | -$78.91M* | (m) | $111.73M* | (m) | (m) | (m) | (m) | $23.79M* | (m) | $601.00K* |
| 2023-03-31 | Rolling | (m) | -$96.89M* | (m) | $104.43M* | (m) | (m) | (m) | (m) | $24.92M* | (m) | $503.00K* |
| 2022-12-31 | Reported | (m) | -$104.26M | (m) | $105.52M | (m) | $11.61M | -$48.61M | (m) | $26.81M | $91.85M | $164.00K |
| 2022-12-31 | Rolling | (m) | -$104.26M* | (m) | $105.52M* | (m) | (m) | (m) | (m) | $26.81M* | $91.85M* | $164.00K* |
| 2021-12-31 | Reported | (m) | -$56.52M | (m) | $110.56M | (m) | $13.68M | -$47.62M | (m) | $28.38M | $92.91M | -$36.00K |
| 2021-09-30 | Rolling | (m) | -$48.62M* | (m) | $106.40M* | (m) | (m) | (m) | (m) | $26.46M* | $82.68M* | -$91.00K* |
| 2021-06-30 | Rolling | (m) | -$31.11M* | (m) | $110.10M* | (m) | (m) | (m) | (m) | $25.03M* | $72.46M* | -$235.00K* |
| 2021-03-31 | Rolling | (m) | -$29.64M* | (m) | $97.86M* | (m) | (m) | (m) | (m) | $22.59M* | $64.77M* | -$294.00K* |
| 2020-12-31 | Reported | (m) | -$31.58M | (m) | $86.38M | (m) | $3.93M | -$23.36M | (m) | $20.17M | $59.59M | -$376.00K |
| 2020-12-31 | Rolling | (m) | -$31.58M* | (m) | $86.38M* | (m) | (m) | (m) | (m) | $20.17M* | $59.59M* | -$376.00K* |
| 2020-09-30 | Rolling | (m) | -$33.14M* | (m) | $76.16M* | (m) | (m) | (m) | (m) | $18.36M* | $54.78M* | -$360.00K* |
| 2020-06-30 | Rolling | (m) | -$45.66M* | (m) | $59.72M* | (m) | (m) | (m) | (m) | $16.90M* | $54.68M* | -$374.00K* |
| 2020-03-31 | Rolling | (m) | -$43.97M* | (m) | $60.12M* | (m) | (m) | (m) | (m) | $16.61M* | $55.01M* | -$333.00K* |
| 2019-12-31 | Reported | (m) | -$41.60M | (m) | $56.73M | (m) | $10.85M | -$26.19M | (m) | $16.19M | $52.25M | -$187.00K |
| 2019-12-31 | Rolling | (m) | -$41.60M* | (m) | $56.73M* | (m) | (m) | (m) | (m) | $16.19M* | $52.25M* | -$187.00K* |
| 2019-09-30 | Rolling | (m) | -$39.53M* | (m) | $51.69M* | (m) | (m) | (m) | (m) | $15.84M* | $48.87M* | -$55.00K* |
| 2019-06-30 | Rolling | (m) | -$36.95M* | (m) | $47.34M* | (m) | (m) | (m) | (m) | $16.32M* | $44.36M* | (m) |
| 2019-03-31 | Rolling | (m) | -$33.74M* | (m) | $42.45M* | (m) | (m) | (m) | (m) | $16.01M* | $38.51M* | (m) |
| 2018-12-31 | Reported | (m) | -$31.55M | (m) | $37.63M | (m) | $1.52M | -$28.72M | (m) | $15.80M | $33.69M | $25.00K |
| 2018-12-31 | Rolling | (m) | -$31.55M* | (m) | $37.63M* | (m) | (m) | (m) | (m) | $15.80M* | $33.69M* | (m) |
| 2018-09-30 | Rolling | (m) | -$29.23M* | (m) | (m) | (m) | (m) | (m) | (m) | $15.69M* | $29.16M* | (m) |
| 2018-06-30 | Rolling | (m) | -$27.95M* | (m) | (m) | (m) | (m) | (m) | (m) | $15.50M* | $25.05M* | (m) |
| 2018-03-31 | Rolling | (m) | -$27.11M* | (m) | (m) | (m) | (m) | (m) | (m) | $15.70M* | $22.21M* | (m) |
| 2017-12-31 | Reported | (m) | -$26.00M | (m) | $22.87M | (m) | $1.13M | -$22.11M | (m) | $16.30M | $19.69M | $0.00 |
| 2017-12-31 | Rolling | (m) | -$26.00M* | (m) | (m) | (m) | (m) | (m) | (m) | $16.30M* | $19.69M* | (m) |
| 2016-12-31 | Reported | (m) | -$21.71M | (m) | (m) | (m) | $526.00K | -$17.74M | (m) | $16.99M | $12.47M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |